icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Mon 3 Aug 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Government websites use the protocol. HTTPS for encryption and security.

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Registered with the Digital Government Authority under number:
20250831619
Suggestions

News

scdaa
icon 2026-06-05

SFDA:AI-Powered 'RASID'Service Cuts Controlled Medication Verification Time for Hajj Pilgrims by 98%

The Saudi Food and Drug Authority (SFDA) has activated the Regulatory AI System for Incoming Drugs (RASID) service to support regulatory operations at...
More
4
icon 2026-06-07

SFDA Grants Orphan Drug Designation to “Gomekli” for the Treatment of Neurofibromatosis Type 1 (NF1)

The Saudi Food and Drug Authority (SFDA) has granted orphan drug designation to Gomekli (mirdametinib), developed by SpringWorks Therapeutics, to...
More
4
icon 2026-06-04

The SFDA Grants Breakthrough Designation to "ZENBEXUS" for the Treatment of Adult Patients with Mult

The Saudi Food and Drug Authority (SFDA) has granted Breakthrough Designation to ZENBEXUS (Iberdomide), developed by Bristol-Myers Squibb, for the...
More
gg
icon 2026-05-29

SFDA CEO Congratulates the Leadership on the Success of the 1447 AH Hajj Season

The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, extended his congratulations to the Custodian of the Two Holy...
More
gg
icon 2026-05-27

SFDA CEO Extends Congratulations to the Wise Leadership on the Occasion of Eid al-Adha

The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, extended his warmest congratulations to the Custodian of the Two...
More
4
icon 2026-05-24

SFDA GrantsBreakthroughDesignation toPrevent and ReduceBleedingEpisodes in Patients with HemophiliaA

The Saudi Food and Drug Authority (SFDA) has granted Novo Nordisk Breakthrough designation to (FREHEMGO), which is indicated as a long-term routine...
More